![First Trust Nasdaq Pharmaceuticals](/common/images/company/N_FTXH.png)
First Trust Nasdaq Pharmaceuticals (FTXH)
NASDAQ
The current FTXH market cap is 0. The company's latest EPS is USD and P/E is N/A.
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 106k | 269k | 301k | 710k | 476k |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | -304k | 3.69M | 1.02M | -156k | 1.84M |
Quarter End | |||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.81M | 19.14M | 17.32M | 32.66M | 21.01M |
Total Liabilities | 2k | 9k | 8k | 18k | 10k |
Total Equity | 5.81M | 19.13M | 17.31M | 32.64M | 21M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 5.85k |
Average Volume (1 Month) | 3.93k |
52 Week Change | 5.40% |
52 Week High | 28.41 |
52 Week Low | 23.85 |
Spread (Intraday) | 9.97 (30.49%) |
Company Name | First Trust Nasdaq Pharmaceuticals |
Address |
155 federal st boston, massachusetts 02110 |
Website | https:// |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.